Somatuline AutoGel 60mg-EU (Lanreotide Injection) 60mg

Somatuline AutoGel 60mg is a prescription injection used for hormone-related conditions like acromegaly and neuroendocrine tumors. This EU-sourced lanreotide formulation comes in a pre-filled syringe for convenience. Store between 2-8°C to maintain stability. Ideal for patients seeking targeted hormone regulation.

Strength

60mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Ipsen

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Somatuline AutoGel 60mg is commonly used to manage symptoms of acromegaly, a condition caused by excess growth hormone. It is also prescribed for neuroendocrine tumors, including those in the pancreas or gastrointestinal tract, to help control hormone production and tumor growth. This medication works by mimicking the action of somatostatin, a natural hormone that regulates hormone secretion.

Side Effects

Patients using Somatuline AutoGel 60mg may experience localized effects at the injection site, such as mild pain or redness. Some individuals report gastrointestinal changes like mild nausea or diarrhea, which often subside as the body adjusts. Regular monitoring helps ensure the medication is well-tolerated over time.

Precautions & Warnings

Keep Somatuline AutoGel 60mg refrigerated between 2-8°C and protect it from light. Do not freeze or shake the syringe vigorously. Inform your healthcare provider about any allergies or medical conditions before use. Always follow the handling instructions provided with the medication to ensure safety and efficacy.

Avoid Interactions

Somatuline AutoGel 60mg may interact with medications that affect heart rhythm, such as antiarrhythmics. Caution is advised when combining it with drugs that influence blood sugar levels, as lanreotide can alter glucose metabolism. Alcohol use may exacerbate certain side effects, so moderation is recommended.

Frequently Asked Questions

It is used to treat acromegaly and neuroendocrine tumors by regulating hormone production.

Store between 2-8°C and avoid freezing or exposure to light.

It is a prescription medication and may be available through licensed online pharmacies.

Mild injection site reactions and gastrointestinal changes like nausea are commonly reported.

Consult a healthcare provider to determine if this medication is appropriate for your condition.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.